Staff

TOP 5 publications:

1. Pedraz-Petrozzi B, Marszalek-Grabska M, Fornal E, Wielgosz A, Stachniuk A, Marzec P, Neumann E, Riedinger E, Gilles M, Gründer G, Danyeli LV, Sen ZD, Walter M, Sartorius A, Spangemacher M, Reinwald JR. Kynurenine pathway profiles as markers of ketamine response in treatment-resistant depression.Brain Behav Immun. 2026 Jul 5. [Epub ahead of print] 138:106889.
2. Pedraz-Petrozzi B, Spangemacher M, Deicher A, Drews L, Defert J, Silva-Colmenero AY, Wein P, Riedinger E, Gründer G, Gilles M, Sartorius A, Reinwald JR. Baseline monocyte count predicts symptom improvement during intravenous ketamine therapy in treatment-resistant depression: a single-arm open-label observational study.Front Psychiatry. 2024 15:1415505.